Blair William & CO Tilray Brands, Inc. Transaction History

Blair William & CO

$31.4 Billion
Q1 2024

A detailed history of Blair William & CO transactions in Tilray Brands, Inc. stock. As of the latest transaction made, Blair William & CO holds 153,789 shares of TLRY stock, worth $253,751. This represents 0.0% of its overall portfolio holdings.

Number of Shares

153,789

Previous 158,289 2.84%

Holding current value

$253,751

Previous $364,000 4.12%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$1.6 - $2.48 $7,200 - $11,160	-4,500 Reduced 2.84%	153,789 $379,000
Q4 2023 Feb 12, 2024	SELL	$1.66 - $2.41 $19 - $28	-12 Reduced 0.01%	158,289 $364,000
Q3 2023 Nov 09, 2023	SELL	$1.55 - $3.31 $9 - $19	-6 Reduced -0.0%	158,301 $378,000
Q2 2023 Aug 11, 2023	SELL	$1.52 - $2.78 $22 - $41	-15 Reduced 0.01%	158,307 $246,000
Q1 2023 May 12, 2023	BUY	$2.36 - $3.35 $35 - $50	15 Added 0.01%	158,322 $400,000

Q4 2022 Feb 10, 2023	SELL	$2.58 - $4.68 $3,310 - $6,004	-1,283 Reduced 0.8%	158,307 $425,000
Q3 2022 Nov 09, 2022	BUY	$2.7 - $4.3 $3,618 - $5,762	1,340 Added 0.85%	159,590 $439,000
Q2 2022 Aug 10, 2022	BUY	$3.11 - $7.48 $31,100 - $74,800	10,000 Added 6.75%	158,250 $494,000
Q1 2022 May 13, 2022	BUY	$4.88 - $8.56 $327,887 - $575,146	67,190 Added 82.89%	148,250 $1.15 Million
Q4 2021 Feb 14, 2022	SELL	$7.03 - $13.03 $487,818 - $904,164	-69,391 Reduced 46.12%	81,060 $570,000
Q3 2021 Nov 12, 2021	BUY	$11.11 - $17.84 $146,296 - $234,917	13,168 Added 9.59%	150,451 $1.7 Million
Q2 2021 Aug 12, 2021	BUY	$13.68 - $22.34 $1.88 Million - $3.07 Million	137,283 New	137,283 $2.48 Million

Others Institutions Holding TLRY

# of Institutions

403

Shares Held

93.4M

Call Options Held

8.9M

Put Options Held

10.4M

View Full List

About Tilray Brands, Inc.

Ticker TLRY
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 611,401,984
Market Cap $1.01B
Description
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...

More about TLRY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account